Sunshine Biopharma Inc. (SBFM) stock
SBFMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFMW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 10/30
$2.60−0.10 (-3.70%)
Close on Nov 16, 2026Market cap $10.08MP/E –Yield –
Sunshine Biopharma gross margin
Gross margin is gross profit as a percentage of revenue.
Sunshine Biopharma's gross margin for the twelve months ending Jun 30, 2026 was 30.3%. For fiscal 2025 it was 33.8%, against 30.6% the year before. The highest annual figure on record is 63.8% in fiscal 2020.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 33.8% | +3.2 |
| FY2024 | Dec 31, 2024 | 30.6% | −4.0 |
| FY2023 | Dec 31, 2023 | 34.6% | −4.4 |
| FY2022 | Dec 31, 2022 | 39.0% | −9.4 |
| FY2021 | Dec 31, 2021 | 48.4% | −15.4 |
| FY2020 | Dec 31, 2020 | 63.8% | +16.1 |
| FY2019 | Dec 31, 2019 | 47.7% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 26.2% | −10.2 |
| Q1 FY2026 | Mar 31, 2026 | 27.0% | −3.7 |
| Q4 FY2025 | Dec 31, 2025 | 35.3% | +3.1 |
| Q3 FY2025 | Sep 30, 2025 | 32.6% | −1.3 |
| Q2 FY2025 | Jun 30, 2025 | 36.4% | +11.0 |
| Q1 FY2025 | Mar 31, 2025 | 30.7% | −0.5 |
| Q4 FY2024 | Dec 31, 2024 | 32.2% | −1.2 |
| Q3 FY2024 | Sep 30, 2024 | 34.0% | +0.6 |
| Q2 FY2024 | Jun 30, 2024 | 25.3% | −9.8 |
| Q1 FY2024 | Mar 31, 2024 | 31.2% | −6.1 |
| Q4 FY2023 | Dec 31, 2023 | 33.4% | −4.4 |
| Q3 FY2023 | Sep 30, 2023 | 33.4% | −17.1 |
| Q2 FY2023 | Jun 30, 2023 | 35.1% | −15.2 |
| Q1 FY2023 | Mar 31, 2023 | 37.4% | −13.9 |
| Q4 FY2022 | Dec 31, 2022 | 37.8% | +9.9 |
| Q3 FY2022 | Sep 30, 2022 | 50.5% | −10.8 |
| Q2 FY2022 | Jun 30, 2022 | 50.3% | −14.7 |
| Q1 FY2022 | Mar 31, 2022 | 51.2% | −2.6 |
| Q4 FY2021 | Dec 31, 2021 | 28.0% | −34.7 |
| Q3 FY2021 | Sep 30, 2021 | 61.3% | −1.8 |
| Q2 FY2021 | Jun 30, 2021 | 65.0% | −0.9 |
| Q1 FY2021 | Mar 31, 2021 | 53.8% | −11.3 |
| Q4 FY2020 | Dec 31, 2020 | 62.6% | +2.3 |
| Q3 FY2020 | Sep 30, 2020 | 63.0% | +35.3 |
| Q2 FY2020 | Jun 30, 2020 | 65.9% | +14.1 |
| Q1 FY2020 | Mar 31, 2020 | 65.0% | +19.4 |
| Q4 FY2019 | Dec 31, 2019 | 60.4% | +70.9 |
| Q3 FY2019 | Sep 30, 2019 | 27.8% | – |
| Q2 FY2019 | Jun 30, 2019 | 51.9% | – |
| Q1 FY2019 | Mar 31, 2019 | 45.6% | – |
| Q1 FY2018 | Mar 31, 2018 | -10.6% | – |
See a number that looks wrong?